Cargando…

Seroconversion and dynamics of the anti-SARS-CoV-2 antibody response related to a hospital COVID-19 outbreak among pediatric oncology patients

Detalles Bibliográficos
Autores principales:	Mayanskiy, Nikolay, Luchkina, Polina, Fedorova, Natalia, Lebedin, Yuri, Ponomareva, Natalia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129958/ https://www.ncbi.nlm.nih.gov/pubmed/34007047 http://dx.doi.org/10.1038/s41375-021-01288-0

Ejemplares similares

Parallel detection of SARS-CoV-2 RNA and nucleocapsid antigen in nasopharyngeal specimens from a COVID-19 patient screening cohort
por: Mayanskiy, Nikolay, et al.
Publicado: (2021)

Healthcare Worker Seroconversion in SARS Outbreak
por: Chow, Pierce K. H., et al.
Publicado: (2004)

SARS-CoV-2 antibody seroconversion in care home
por: Shang, Joan, et al.
Publicado: (2020)

Seroconversion in household members of COVID-19 outpatients
por: Cox, Rebecca J, et al.
Publicado: (2021)

COVID19 seroconversion in an unrelated stem cell donor
por: Maakaron, Joseph E., et al.
Publicado: (2020)

SARS-COV-2 INFECTION AND SEROCONVERSION IN PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS
por: Ruan, Wenly, et al.
Publicado: (2021)

Seroconversion in patients with cancer and oncology health care workers infected by SARS-CoV-2
por: Marra, A., et al.
Publicado: (2021)

1603P SARS-CoV-2 seroconversion among oncology healthcare workers in Brazil
por: Ismael, C., et al.
Publicado: (2021)

Dynamics of anti-SARS-CoV-2 seroconversion in individual patients and at the population level
por: Szewczyk-Dąbrowska, Alina, et al.
Publicado: (2022)

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran
por: Nazemipour, Maryam, et al.
Publicado: (2021)

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran
por: Ghafari, Mahan, et al.
Publicado: (2021)

Immunoassays for anti-SARS-CoV-2 antibodies: recent insights
por: Van Elslande, Jan, et al.
Publicado: (2021)

Seroconversion Following SARS-CoV-2 Infection or Vaccination in Pediatric IBD Patients
por: Spencer, Elizabeth A, et al.
Publicado: (2021)

The impacts of the novel SARS-CoV-2 outbreak on surgical oncology - A letter to the editor on “The socio-economic implications of the coronavirus and COVID-19 pandemic: A review”
por: Shubber, Nour, et al.
Publicado: (2020)

Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement
por: Zang, Jinkai, et al.
Publicado: (2020)

Assessment of Seroconversion to SARS-CoV-2 in a Cohort of Pediatric Kidney Transplant Recipients
por: Nailescu, Corina, et al.
Publicado: (2020)

Longitudinal SARS-CoV-2 seroconversion and functional heterogeneity in a pediatric dialysis unit
por: Canas, Jorge J., et al.
Publicado: (2021)

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran – Authors' reply
por: Darvishian, Maryam, et al.
Publicado: (2021)

Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak
por: Stringhini, Silvia, et al.
Publicado: (2021)

No crossreactivity of anti-SARS-CoV-2 spike protein antibodies with Syncytin-1
por: Prasad, Mukul, et al.
Publicado: (2021)

Specificity and cross-reactivity of a test for anti-SARS-CoV-2 antibodies
por: Choy, Kay Weng
Publicado: (2021)

SARS-CoV-2 and Europe: timing of containment measures for outbreak control
por: Li, Chenyu, et al.
Publicado: (2020)

Seroconversion dynamic and SARS-CoV-2 seropositivity in unvaccinated population during the first and second outbreaks in Mexico
por: Fernández-Rojas, Miguel A., et al.
Publicado: (2022)

Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection
por: Lin, Qingqing, et al.
Publicado: (2020)

Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19
por: Ibarrondo, F. Javier, et al.
Publicado: (2020)

Anti-SARS-CoV-2 antibodies in healthy donor plasma pools and IVIG products
por: Romero, Carolina, et al.
Publicado: (2021)

Asymptomatic individuals positive for anti-SARS-CoV-2 antibodies negative on molecular swab
por: Antonelli, Guido, et al.
Publicado: (2021)

Correspondence on Body Weight, Anti-SARS-CoV-2 Antibody and mRNA Vaccination
por: Sookaromdee, Pathum, et al.
Publicado: (2023)

Kinetics and seroprevalence of SARS-CoV-2 antibodies in children
por: Roarty, Cathal, et al.
Publicado: (2021)

The presence of SARS-CoV2 antibodies in MS patients
por: Wallach, Asya I., et al.
Publicado: (2021)

COVID-19 Pandemic: The Challenges for Pediatric Oncology
por: Seth, Rachna
Publicado: (2020)

Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV
por: Zheng, Ming, et al.
Publicado: (2020)

COVID-19 Seroconversion in Emergency Professionals at an Urban Academic Emergency Department in New York City
por: Jeong, Jordan M., et al.
Publicado: (2020)

Anti-SARS-CoV-2 antibodies in healthy donor plasma pools and IVIG products—an update
por: Romero, Carolina, et al.
Publicado: (2022)

Specificity and cross-reactivity of a test for anti-SARS-CoV-2 antibodies – Authors' reply
por: Iversen, Kasper, et al.
Publicado: (2021)

Measles Immunization: Worth Considering Containment Strategy for SARS-CoV-2 Global Outbreak
por: Hanker, Varnit S.
Publicado: (2020)

Available COVID-19 serial seroconversion panel for validation of SARS-CoV-2 antibody assays.
por: Belda, Francisco, et al.
Publicado: (2021)

Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients
por: Tuaillon, E, et al.
Publicado: (2020)

Early seasonal coronavirus seroconversion did not produce cross-protective SARS-CoV-2 antibodies
por: Wong, Lydia Su Yin, et al.
Publicado: (2023)

Antibody response to SARS-CoV-2 in people living with HIV
por: Yamamoto, Shinya, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g1fu9ltokbpddgfpo59lv53ln7